Review
Open access
Sep 2026
The next-generation biomarkers in early-stage triple negative breast cancer.
Multibiomarker integration, supported by prospective validation and automated models, represents a promising approach to personalize treatment algorithms in early-stage TNBC, balancing efficacy and toxicity while guiding escalation and de-escalation strategies.
Federica Falcone, Erica Pietroluongo, P. De Placido
· Current Opinion in Oncology · 0 citations